Skip to Main Content

Advertisement

Skip Nav Destination

Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma

J Cell Biol (2010) 188 (6): 851–862.
Currently there are no citedby results. Try again later.

or Create an Account

Close Modal
Close Modal